School of Pharmacy, University of Wisconsin-Madison, Madison, WI, 53705, USA.
Department of Chemistry, University of Wisconsin-Madison, Madison, WI, 53706, USA.
Eur J Med Chem. 2022 Jun 5;236:114317. doi: 10.1016/j.ejmech.2022.114317. Epub 2022 Apr 1.
Proteolysis targeting chimera (PROTAC) is one of the most frequently used technologies for targeted protein degradation. PROTACs are composed of target protein ligand, E3 ligase ligand and a linker between them. Traditional methods for the development of PROTACs involve step-by-step synthesis and are time consuming. Herein, we report a platform for the rapid synthesis of PROTACs (Rapid-TAC) via a traceless coupling reaction between ortho-phthalaldehyde (OPA) motif on the ligand of targeting protein and an amine fucntional group on the commercially available partial PROTAC library that is composed of different E3 ligase ligands and various types and lengths of linkers. Under our optimized miniaturized conditions, the full PROTACs can be synthesized in a high throughput manner and the products can be directly used for screening without any further manipulations including purification. We demonstrated the utility of this platform by quickly identifying active degraders for androgen receptor (AR) and BRD4 with DC of 41.9 nM and 8.9 nM, respectively. It is expected that this Rapid-TAC platform can be easily extended to many other targets, thus lowering the barrier to access this novel modelity for small molecule drug discovery and faciliate structure activity relationship studies.
蛋白水解靶向嵌合体(PROTAC)是靶向蛋白降解最常用的技术之一。PROTAC 由靶蛋白配体、E3 连接酶配体和它们之间的连接子组成。传统的 PROTAC 开发方法涉及逐步合成,耗时较长。在此,我们报告了一种通过靶向蛋白配体上邻苯二醛(OPA)基序与市售部分 PROTAC 文库中的胺功能基团之间的无痕偶联反应快速合成 PROTAC(Rapid-TAC)的平台,该文库由不同的 E3 连接酶配体和各种类型和长度的连接子组成。在我们优化的微型化条件下,可以高通量地合成完整的 PROTAC,并且可以直接用于筛选,无需任何进一步的操作,包括纯化。我们通过快速鉴定雄激素受体(AR)和 BRD4 的有效降解剂,证明了该平台的实用性,其 DC 值分别为 41.9 nM 和 8.9 nM。预计该 Rapid-TAC 平台可以很容易地扩展到许多其他靶标,从而降低小分子药物发现和促进构效关系研究这一新型模式的准入门槛。